Pankaj Agrawal, MD, MMSc

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

ImageDr. Agrawal is the Principal Investigator for The Manton Center's Gene Discovery Core. He is in charge of overseeing participant recruitment and data flow for the Core. Dr. Agrawal's personal research is focused on identifying genetic and molecular basis of congenital myopathies that include nemaline myopathy (NM) and multiminicore disease (MMD). Working in the Beggs' Laboratory, he recently identified cofilin-2 gene (CFL2) to be mutated in two siblings with NM. His research interests also include finding new genes that when mutated cause rare disorders in neonates/early infants. Clinically, Dr. Agrawal cares for patients in Children's Hospital's Neonatal Intensive Care Unit.

Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
Condition & Treatments
Search for a Condition or Treatment:
View allSearch
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO